Rating History for MBX Biosciences Inc (MBX) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/21/2026 | Jessica Fye | New Coverage | Overweight (N/A) |
88.00 (N/A) |
68.40 (60.93) |
-10.92% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/21/2026 | Jessica Fye | New Coverage | Overweight (N/A) |
88.00 (N/A) |
68.40 (60.93) |
-10.92% | Details |
![]() |
|||||||